Burkina Faso vs Rwanda: Treatment coverage for schistosomiasis
Burkina Faso
89.0%
in 2024
Rwanda
100.0%
in 2024
Burkina Faso rank
4th
Rwanda rank
1st
Treatment coverage for schistosomiasis over time
- Burkina Faso
- Rwanda
How they compare
Rwanda currently reports 100.0% against 89.0% in Burkina Faso, a difference of 11.0%.
That makes Rwanda's figure about 1.1 times Burkina Faso's.
The two have swapped places 3 times across 14 shared years of data; in 2008 it was Burkina Faso ahead.
Burkina Faso ranks 4th and Rwanda ranks 1st of 45 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 2 and Rwanda in 1.
Head to head by decade
| Decade | Burkina Faso | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.8% | 23.8% | 1.9% | Burkina Faso |
| 2010s | 87.8% | 28.3% | 59.4% | Burkina Faso |
| 2020s | 72.6% | 91.2% | 18.6% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Burkina Faso or Rwanda?
- Rwanda, at 100.0% against 89.0% in Burkina Faso as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Burkina Faso and Rwanda?
- 11.0%, with Rwanda ahead.
- How many years of comparable data are there for Burkina Faso and Rwanda?
- 14 years are reported by both, from 2008 to 2024.
- How do Burkina Faso and Rwanda rank globally for treatment coverage for schistosomiasis?
- Burkina Faso ranks 4th and Rwanda ranks 1st of 45 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.